metastatic renal cell carcinoma

Metastatic renal cell carcinoma (mRCC) imhando yegomarara reitsvo rakapararira kune dzimwe nhengo dzemuviri. Sarudzo dzekurapa dzinosiyana zvichienderana nedanho uye hunhu hwegomarara, asi kazhinji dzinosanganisira kurapa kwakanangwa, immunotherapy, kuvhiyiwa, uye neradiation therapy. Kuonekwa kwekutanga uye nzira dzekurapa dzakakosha pakuvandudza mhedzisiro yevarwere vane mRCC. Gwaro iri rinopa tsananguro yakadzama yemRCC, inovhara zvikonzero zvayo, zviratidzo, kuongororwa, nzira dzokurapa, uye fungidziro.Chii chinonzi Renal Cell Carcinoma uye Metastasis?Renal cell carcinoma (RCC) ndiyo inowanzozivikanwa yekenza yeitsvo muvanhu vakuru. Inobva mumucheka we proximal convoluted tubule, machubhu madiki muitsvo anosefa ropa nekubvisa tsvina. Kana RCC ichiita metastasizes, zvinoreva kuti masero egomarara abva pabundu rekutanga muitsvo uye akapararira kune dzimwe nzvimbo dzemuviri, semapapu, mapfupa, uropi, kana chiropa. Kana yapararira, inorongwa se metastatic renal cell carcinoma (mRCC) .Zvikonzero uye Risk Factors of Renal Cell CarcinomaChikonzero chaicho cheRCC hachinyatsojeka, asi zvinhu zvakawanda zvinogona kuwedzera njodzi yekuva nechirwere ichi: Kusvuta: Vanosvuta vari panjodzi huru yekugadzira RCC zvichienzaniswa nevasingasvuti. Kufutisa: Kufutisa kana kufutisa kwakabatana nenjodzi yakawedzera. High Blood Pressure: Chisingaperi high blood pressure inogona kukuvadza itsvo uye kuwedzera njodzi yegomarara. Nhoroondo Yemhuri: Kuva nenhoroondo yemhuri yeRCC kunowedzera njodzi yako. Mamwe mamiriro ekugara nhaka, akadai sechirwere chevon Hippel-Lindau (VHL), Birt-Hogg-Dube syndrome, uye nhaka yepillary renal cell carcinoma, inosanganiswa nenjodzi huru. Chirwere cheKidney chepamusoro kana Dialysis: Vanhu vane chirwere chetsvo chisingaperi, kunyanya avo vari kuita dialysis, vane ngozi yakawanda. Kusangana neMamwe Makemikari: Kusangana nebasa kune cadmium, trichlorethylene, nemimwe mishonga yesora yakabatana neRCC.Zviratidzo zveMetastatic Renal Cell CarcinomaPakutanga-danho reRCC kazhinji harina zviratidzo. Sezvo bundu rinokura kana kuti metastasizes, zviratidzo zvinogona kuoneka. Izvi zvinogona kusiyana zvichienderana nekuti gomarara rakapararira kupi, asi zviratidzo zvakajairika zve metastatic renal cell carcinoma sanganisira: Ropa muweti (hematuria) Kurwadza kunoramba kuripo parutivi kana musana Bundu kana kuwanda mudivi kana musana Kupera uremu kusingatsananguriki Kupera simba Kupera simba kusingakonzerwi nechirwere Anemia (yakaderera masero matsvuku eropa) Marwadzo emapfupa (kana kenza yapararira kusvika kumapfupa) Kuzvimba muzviziso nemakumboKuongororwa kweMetastatic Renal Ceall metastatic renal cell carcinoma kazhinji zvinosanganisira musanganiswa webvunzo dzemuviri, bvunzo dzekufungidzira, uye biopsies. Physical Exam: Chiremba achaita bvunzo yemuviri kuti atarise chero abnormalities. Kufungidzira Miedzo: CT Scan: A CT scan inopa yakadzama mifananidzo yeitsvo uye yakatenderedza tishu uye inogona kubatsira kuona mapundu uye kuongorora hukuru hwavo nenzvimbo. MRI: MRI inogona kupa mifananidzo yakawanda uye inowanzoshandiswa kuongorora kukura kwekenza. Bone Scan: Bone scan inoshandiswa kuona kana gomarara rapararira kusvika kumapfupa. PET Scan: A PET scan inogona kubatsira kuona masero egomarara mumuviri wese. Biopsy: A biopsy inosanganisira kubvisa sampuli diki yetishu kubva muitsvo kana metastatic site yekuongororwa pasi pe microscope. Izvi zvinosimbisa kuongororwa kweRCC uye zvinobatsira kuziva rudzi rweRCC.Kurapa Options for Metastatic Renal Cell CarcinomaKurapa metastatic renal cell carcinoma zvinoenderana nezvinhu zvakati kuti, zvinosanganisira kukura kwegomarara, utano hwemurwere hwese, uye zvakaita bundu racho. Sarudzo dzekurapa dzakajairwa dzinosanganisira: Targeted TherapyTargeted therapy mishonga inonangana nemamorekuru ane chekuita negomarara masero kukura uye kurarama. Mishonga iyi inogona kubatsira kuderedza kukura kwegomarara uye kuvandudza huwandu hwekupona. Mishonga yakajairika yemRCC inosanganisira: VEGF inhibitors (semuenzaniso, sunitinib, sorafenib, pazopanib, axitinib, cabozantinib): Mishonga iyi inovhara vascular endothelial growth factor (VEGF) nzira, iyo yakakosha pakuumbwa kwetsinga yeropa mumamota. mTOR inhibitors (somuenzaniso, everolimus, temsirolimus): Mishonga iyi inovhara mammalian target of rapamycin (mTOR) nzira, iyo inobatanidzwa mukukura kwesero uye metabolism.ImmunotherapyImmunotherapy mishonga inobatsira muviri wekuzvidzivirira kuziva uye kurwisa masero ekenza. Iyi mishonga yakaratidza mhedzisiro inovimbisa mukurapa mRCC. Kazhinji immunotherapies yemRCC inosanganisira: Checkpoint inhibitors (somuenzaniso, nivolumab, pembrolizumab, ipilimumab): Mishonga iyi inovhara mapuroteni pamasero ekudzivirira anodzivirira kurwisa masero ekenza.Kuvhiyiwa kunogona kuva sarudzo yekubvisa itsvo (nephrectomy) kana kubvisa mazamu emetastatic mune dzimwe nhengo dzomuviri. Izvi zvinogona kubatsira kubvisa zviratidzo uye kuvandudza hupenyu hwehupenyu. Cytoreductive nephrectomy inosanganisira kubvisa bundu reitsvo yekutanga kunyangwe gomarara rapararira kune dzimwe nhengo dzemuviri. Izvi zvinogona kuvandudza kushanda kwemamwe marapirwo.Radiation TherapyRadiation therapy inoshandisa matanda ane simba guru kuuraya masero egomarara. Inogona kushandiswa kubvisa marwadzo kana zvimwe zviratidzo zvinokonzerwa nemararamiro emarara, kunyanya mumapfupa kana uropi.Clinical TrialsClinical miedzo itsvakurudzo yezvidzidzo inoongorora mishonga mitsva yekenza. Varwere vane metastatic renal cell carcinoma vangafunga kutora chikamu muchirongwa chekiriniki kuti uwane nzira dzekucheka-kumucheto marapirwo.Prognosis of Metastatic Renal Cell CarcinomaThe prognosis for metastatic renal cell carcinoma zvinosiyana zvichienderana nezvinhu zvakati kuti, zvinosanganisira kukura kwegomarara, utano hwemurwere hwese, uye mhinduro pakurapwa. Nhoroondo, mRCC yaive nehurombo husina kunaka, asi kufambira mberi mukurapa kwakanangwa uye immunotherapy kwakavandudza zvakanyanya mhedzisiro yevarwere vazhinji. Zvinhu zvinogona kukanganisa kufungidzira zvinosanganisira International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk score, iyo inotarisa zvinhu zvakadai senguva kubva pakuongororwa kusvika pakurapwa, maitiro ekushanda, hemoglobin level, calcium level, neutrophil count, uye platelet count.Kurarama neMetastatic Renal Cell CarcinomaKurarama ne metastatic renal cell carcinoma zvinogona kuva zvakaoma, zvose mumuviri nomupfungwa. Zvakakosha kuve nerutsigiro rwakasimba uye kutora matanho ekugadzirisa zviratidzo nemhedzisiro yekurapwa. Izvi zvinogona kusanganisira: Kudzora marwadzo Rutsigiro rwekudya kunovaka muviri Kuekisesaiza uye kurapa kwemuviri Kupanga mazano kana mapoka ekutsigira Basa reShandong Baofa Cancer Research InstituteAt. Shandong Baofa Cancer Research Institute, takazvipira kupa hutano hwakakwana uye hutsva hwegomarara. Takazvipira kufambisira mberi tsvagiridzo yegomarara uye kupa varwere kurapwa kwakanyanya. Chikwata chedu chemaoncologists ane ruzivo, vanachiremba, uye vashandi vekutsigira vanoshanda pamwe chete kugadzira zvirongwa zvekurapa zvemurwere wega wega nechinangwa chekuvandudza hupenyu uye kupona kwese. Tinovavarira kupa kufambira mberi mukurapa cancer, kusanganisira kurapwa kwakanangwa, immunotherapies, uye miedzo yekiriniki. Future Directions muMetastatic Renal Cell Carcinoma Research metastatic renal cell carcinoma iri kuenderera mberi, nechinangwa chekugadzira mishonga mitsva uye inoshanda zvakanyanya. Nzvimbo dzazvino dzekutsvaga dzinosanganisira: Kugadzira nzira itsva dzekurapa dzakanangwa uye immunotherapies Kuziva ma biomarkers anogona kufanotaura mhinduro kukurapa Kunzwisisa nzira dzekupokana nekwakanangwa kurapwa uye immunotherapy Kugadzira nzira nyowani dzekudzivirira kupararira kweRCCBy kuenderera mberi nekufambisira mberi kunzwisisa kwedu kwemRCC, tinogona kuvandudza mhedzisiro yevarwere vane chirwere ichi chakaoma.